Cargando…

Dendritic Cell Activation in Leprosy Using CD1a and Factor XIIIa Markers

Background: Leprosy is manifested in varied forms based on the immune status of the patient giving rise to the polar and borderline spectrum of tuberculoid (TT) and lepromatous leprosy (LL). The present study was conducted to assess the macrophage activation in the spectrum of leprosy using CD1a and...

Descripción completa

Detalles Bibliográficos
Autores principales:	K, Kavithamani, S, Sowmya, K, Shanmugasamy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201461/ https://www.ncbi.nlm.nih.gov/pubmed/37223172 http://dx.doi.org/10.7759/cureus.37968

Ejemplares similares

Ethacrynic acid is an inhibitor of human factor XIIIa
por: Kar, Srabani, et al.
Publicado: (2022)

Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1
por: De Simone, Ilaria, et al.
Publicado: (2022)

Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
por: Suman, Sweta, et al.
Publicado: (2023)

Leprosy Classification, Clinical Features, Epidemiology, and Host Immunological Responses: Failure of Eradication in 2023
por: Alrehaili, Jihad
Publicado: (2023)

Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH)
por: Arati, S., et al.
Publicado: (2019)

Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity
por: Kreutz, Rolf P., et al.
Publicado: (2018)

Tissue immunostaining for factor XIIIa in dermal dendrocytes of pityriasis alba skin lesions()
por: Carneiro, Francisca Regina Oliveira, et al.
Publicado: (2014)

Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens
por: Palaçon, Mariana Paravani, et al.
Publicado: (2023)

Mass Spectrometric Identification of a Novel Factor XIIIa Cross-Linking Site in Fibrinogen
por: Semkova, Mariya E., et al.
Publicado: (2021)

Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase
por: Gates, Eric W. J., et al.
Publicado: (2023)

Prevalence and Risk Factors of Surgical Site Infections in a Teaching Medical College in the Trichy District of India
por: Mohan, Nivitha, et al.
Publicado: (2023)

Dendritic cell density and activation status in human breast cancer – CD1a, CMRF-44, CMRF-56 and CD-83 expression
por: Coventry, B J, et al.
Publicado: (2002)

Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile
por: Al-Horani, Rami A., et al.
Publicado: (2016)

Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking
por: Porrello, Alessandro, et al.
Publicado: (2018)

Plasma Membrane Factor XIIIA Transglutaminase Activity Regulates Osteoblast Matrix Secretion and Deposition by Affecting Microtubule Dynamics
por: Al-Jallad, Hadil F., et al.
Publicado: (2011)

Aldehyde Dehydrogenase: An Off-Label Marker of Endothelial Activation in Oral Squamous Cell Carcinoma
por: Andreadis, Dimitrios, et al.
Publicado: (2023)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

Non-invasive in vivo imaging of acute thrombosis: development of a novel factor XIIIa radiotracer
por: Andrews, Jack P M, et al.
Publicado: (2020)

Evidence of Continued CD4+ and CD8+ T Cell Activity After SARS-COV-2 Clearance in a Late COVID-19 Pneumonia Heart Transplant Patient
por: Klein, Francisco R, et al.
Publicado: (2022)

A Case of Atypical Hairy Cell Leukemia With CD10+ and CD38+: Diagnosis and Treatment
por: Tuan Nguyen, Tung, et al.
Publicado: (2022)

Mast cell–derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections
por: Piliponsky, Adrian M., et al.
Publicado: (2022)

Utility of CD44/CD24 in the Outcome and Prognosis of Oral Squamous Cell Carcinoma: A Systematic Review
por: Poothakulath Krishnan, Reshma, et al.
Publicado: (2023)

The Utility of the Neutrophil-Lymphocyte Ratio as an Early Diagnostic Marker in Neonatal Sepsis
por: Panda, Santosh K, et al.
Publicado: (2021)

Prognostic Value of TRPM7 Expression and Factor XIIIa-Expressing Tumor-Associated Macrophages in Gastric Cancer
por: Calik, Muhammet, et al.
Publicado: (2021)

CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer
por: Coventry, B J, et al.
Publicado: (2003)

Soluble Programmed Death-Ligand 1 (sPD-L1) as a Promising Marker for Head and Neck Squamous Cell Carcinoma: Correlations With Clinical and Demographic Characteristics
por: Alrehaili, Amani A, et al.
Publicado: (2023)

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
por: Kristiansen, G, et al.
Publicado: (2003)

CD38 – Negative Anaplastic Plasma Cell Myeloma: A Rare Case Report
por: Thi Vinh Do, An, et al.
Publicado: (2022)

Distribution of CD163-positive cell and MHC class II-positive cell in the normal equine uveal tract
por: SANO, Yuto, et al.
Publicado: (2015)

Inflammatory Myofibroblastic Tumor of the Testis in a Patient With Cecal Carcinoma
por: Chandramouli, R, et al.
Publicado: (2023)

Immunohistochemical Evaluation of S100, Alpha-Smooth Muscle Actin, Podoplanin, Matrix Metalloproteinase 13, and Human Epidermal Growth Factor Receptor 2neu Markers in Basal Cell Carcinoma Variants
por: Jabour, Shatha A, et al.
Publicado: (2022)

Intestinal Stem Cell Marker ASCL2 is a Novel Prognostic Predictor in Esophageal Adenocarcinoma
por: Shibahara, Yukiko, et al.
Publicado: (2022)

Frequency of CD34 and CD10 Expression in Adolescent and Young Adult Patients Having Precursor B-cell Acute Lymphoblastic Leukemia and Its Correlation With Clinical Outcomes: A Single-Center Study
por: Ali Shah, Munawar, et al.
Publicado: (2022)

DOG-1 as a Myoepithelial Marker in Discriminating Invasive Breast Carcinomas From Non-Invasive Breast Lesions
por: Perumandal, Sushmitha, et al.
Publicado: (2023)

Accuracy of Classifying Lung Carcinoma Using Immunohistochemical Markers on Limited Biopsy Material: A Two-Center Study
por: Hassan, Amber, et al.
Publicado: (2022)

Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa
por: Sheffield, William P, et al.
Publicado: (2011)

CD30-Positive Anaplastic Variant of Diffuse Large B-cell Lymphoma: Frequency and Association With Clinicopathological Parameters
por: Hashmi, Atif A, et al.
Publicado: (2021)

CD157 Can Replace CD24 and CD14 in a Single-Tube Flow-Cytometric Assay to Detect Paroxysmal Nocturnal Hemoglobinuria (PNH) Clones on Both Neutrophils and Monocytes: A Prospective Study From North India
por: Deka, Roopam, et al.
Publicado: (2022)

The Role of Immunohistochemical Markers in the Diagnosis of Early Myocardial Infarction
por: Buğra, Aytül, et al.
Publicado: (2022)

Validation of Hematological Markers in Early Onset Neonatal Sepsis
por: Rana, Deepshikha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_co3hijg53pfk8cho3q9r9st6gu